Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients?
Abstract
Aim:
The effect of systematic retroperitoneal lymphadenectomy (SRL) remains
controversial in patients with advanced epithelial ovarian cancer (aEOC)
who are optimally debulked.
Conclusion: Our data suggest that aEOC patients with optimal cytoreduction who underwent SRL did not show a significant improvement in survival irrespective of each histological type.
Conclusion: Our data suggest that aEOC patients with optimal cytoreduction who underwent SRL did not show a significant improvement in survival irrespective of each histological type.